Galena Biopharma (GALE) Reports Q3 Loss of $0.13
Tweet
Share
E-mailGet Alerts GALE Hot Sheet
Join SI Premium – FREE
Galena Biopharma (NASDAQ: GALE) reported Q3 EPS of ($0.13), versus ($0.16) reported last year.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Freightos Limited (CRGO) Tops Q2 EPS by 3c ; Offers Guidance
- Citius Pharmaceuticals (CTXR) Misses Q3 EPS by 37c
- Vislink Technologies Inc. (VISL) Misses Q2 EPS by 7c
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
